| Electrostatic Screening of Charged Defects in Monolayer MoS2 TL Atallah, J Wang, M Bosch, D Seo, RA Burke, O Moneer, J Zhu, ... The journal of physical chemistry letters 8 (10), 2148-2152, 2017 | 51 | 2017 |
| An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19: Analysis reviews the Food and Drug Administration's critical vaccine approval role … AS Kesselheim, JJ Darrow, M Kulldorff, BL Brown, M Mitra-Majumdar, ... Health Affairs 40 (1), 25-32, 2021 | 49 | 2021 |
| Agreement of treatment effects from observational studies and randomized controlled trials evaluating hydroxychloroquine, lopinavir-ritonavir, or dexamethasone for covid-19 … O Moneer, G Daly, JJ Skydel, K Nyhan, P Lurie, JS Ross, JD Wallach bmj 377, 2022 | 17 | 2022 |
| Direct-to-consumer personal genomic tests need better regulation O Moneer, JE Miller, ND Shah, JS Ross Nature Medicine 27 (6), 940-943, 2021 | 10 | 2021 |
| New drug postmarketing requirements and commitments in the US: a systematic review of the evidence O Moneer, BL Brown, J Avorn, JJ Darrow, M Mitra-Majumdar, KW Joyce, ... Drug Safety 45 (4), 305-318, 2022 | 8 | 2022 |
| Fulfillment of postmarket commitments and requirements for new drugs approved by the FDA, 2013-2016 BL Brown, M Mitra-Majumdar, JJ Darrow, O Moneer, C Pham, J Avorn, ... JAMA Internal Medicine 182 (11), 1223-1226, 2022 | 6 | 2022 |
| Covid-19, single-sourced diagnostic tests, and innovation policy C Deb, O Moneer, WN Price Journal of Law and the Biosciences 7 (1), lsaa053, 2020 | 4 | 2020 |
| Aligning US Agency Policies for Cardiovascular Devices Through the Breakthrough Devices Program O Moneer, VK Rathi, JL Johnston, JS Ross, SS Dhruva JAMA cardiology 8 (12), 1174-1181, 2023 | 3 | 2023 |
| Characteristics of postmarketing studies for vaccines approved by the US Food and Drug Administration, 2006-2020 O Moneer, CWC Lee, J Avorn, AS Kesselheim JAMA Network Open 4 (4), e218530-e218530, 2021 | 2 | 2021 |
| Generating evidence during a pandemic: what’s reliable? JD Wallach, O Moneer, JS Ross bmj 377, 2022 | | 2022 |
| Electrostatic Screening of Charged Defects in 2D Materials T Atallah, M Bosch, J Wang, D Seo, O Moneer, J Zhu, D Ajayi, J Ardelean, ... APS March Meeting Abstracts 2017, R30. 001, 2017 | | 2017 |
| Comment on CMS Coverage with Evidence Development Proposed Guidance Document MD Maryam Mooghali, O Moneer, N Chaudhry, R Ramachandran | | |
| Agreement of treatment effects estimates from observational studies and randomized clinical trials evaluating therapeutics for COVID-19 O Moneer, G Daly, JJ Skydel, K Nyhan, P Lurie, JS Ross, JD Wallach | | |
